Sen. Karina Villa supports SB2762 mandating insurance coverage for prescribed seizure detection devices

Sen. Karina Villa (D-25th) backed SB2762 with a Yes vote on May 31, 2026, during the 104th General Assembly. The bill, which mandates insurance coverage for medically prescribed seizure detection devices, passed the Illinois Senate 53-5, according to the Illinois Senate.

The official bill language describes it as: "INS-SEIZURE DETECTION DEVICE."

This summary, based on the actual bill text, seeks to clarify its main provisions and effect.

The legislation requires nearly all individual and group health insurance plans, including those sponsored by the state, local governments, schools, HMOs, limited health service organizations, voluntary health service plans, and Medicaid, to provide coverage for medically prescribed seizure detection devices beginning Jan. 1, 2027. Qualifying devices are defined as those cleared by the FDA for monitoring, predicting, alerting, or gathering data on seizures. The measure prohibits prior authorization and almost all patient cost sharing, except where an exception is needed to maintain eligibility for high-deductible health plans with health savings accounts. The bill takes effect when signed into law.

For SB2762, the recorded action noted was 'House Floor Amendment No. 3 Senate Concurs.'

Villa, a Democrat, has represented Illinois' 25th Senate District since being elected in 2021, succeeding former state senator Jim Oberweis.

In Illinois, proposed bills must go through a multi-step process that starts with their introduction in either legislative chamber, proceeds to committee review, floor debate, and requires passage in both chambers before heading to the governor for final approval or veto. The General Assembly is biennial; while thousands of bills may be proposed in each session, a comparatively small number become law.